SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-17-032942
Filing Date
2017-05-16
Accepted
2017-05-16 06:32:53
Documents
9

Document Format Files

Seq Description Document Type Size
1 8-K a17-13113_18k.htm 425 57436
2 EX-2.1 a17-13113_1ex2d1.htm EX-2.1 796014
3 EX-2.2 a17-13113_1ex2d2.htm EX-2.2 63146
4 EX-2.3 a17-13113_1ex2d3.htm EX-2.3 55826
5 EX-2.4 a17-13113_1ex2d4.htm EX-2.4 41176
6 EX-99.1 a17-13113_1ex99d1.htm EX-99.1 32842
7 EX-99.2 a17-13113_1ex99d2.htm EX-99.2 13675
8 GRAPHIC g131131mm01i001.jpg GRAPHIC 4229
9 GRAPHIC g131131mm01i002.jpg GRAPHIC 4549
  Complete submission text file 0001104659-17-032942.txt   1074039
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Filed by) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Subject) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37566 | Film No.: 17846968
SIC: 2834 Pharmaceutical Preparations